Lifestance Health Group (LFST) closed at $11.74 on October 16, 2026, down 5.1% from the previous close, on volume of 2,568,179 shares (30-day average 4,714,089).
Data as of October 16, 2026.
LifeStance Health Board Member Announces Planned Year-End Resignation
TipRanks (Fri, 16-Oct 5:49 PM ET)
LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026
Globe Newswire (Thu, 15-Oct 4:10 PM ET)
Lifestance Health Group (LFST) Receives a Buy from Canaccord Genuity
TipRanks (Thu, 15-Oct 7:56 AM ET)
PRNewswire (Wed, 30-Sep 9:01 AM ET)
LifeStance Health Group Announces Pricing of Secondary Public Offering
Globe Newswire (Wed, 9-Sep 9:15 AM ET)
LifeStance Health Group Announces Launch of Secondary Public Offering
Globe Newswire (Wed, 9-Sep 7:00 AM ET)
LifeStance to Present at Upcoming Investor Conferences
Globe Newswire (Tue, 1-Sep 4:10 PM ET)
LifeStance Survey Finds Women Want Mental Healthcare Built Into Perimenopause and Menopause Care
PRNewswire (Tue, 11-Aug 9:04 AM ET)
LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook
Globe Newswire (Thu, 6-Aug 6:00 AM ET)
LifeStance to Host Second Quarter 2026 Earnings Conference Call on August 6, 2026
Globe Newswire (Thu, 16-Jul 4:10 PM ET)
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
Lifestance Health Group trades on the NASDAQ stock market under the symbol LFST.
As of October 16, 2026, LFST stock price declined to $11.74 with 2,568,179 million shares trading.
LFST has a beta of 0.22, meaning it tends to be less sensitive to market movements. LFST has a correlation of 0.00 to the broad based SPY ETF.
LFST has a market cap of $4.46 billion. This is considered a Mid Cap stock.
Last quarter Lifestance Health Group reported $435 million in Revenue and $.06 earnings per share. This beat revenue expectation by $21 million and missed earnings estimates by -$.01.
In the last 3 years, LFST traded as high as $13.56 and as low as $3.74.
The top ETF exchange traded funds that LFST belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.
LFST has outperformed the market in the last year with a return of +126.2%, while the SPY ETF gained +15.9%. In the last 3 month period, LFST beat the market returning +7.0%, while SPY returned +1.4%. However, in the most recent 2 weeks LFST has underperformed the stock market by returning -1.4%, while SPY returned -0.1%.
LFST support price is $12.11 and resistance is $12.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFST shares will trade within this expected range on the day.
